RAPA-501 Therapy of ALS Expanded Access Protocol
NCT06169176
·
clinicaltrials.gov ↗
TEMPORARILY_NOT_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis
Interventions
OTHER:
RAPA-501 Autologous T stem cells
Sponsor
Rapa Therapeutics LLC
Collaborators
Massachusetts General Hospital
National Institute of Neurological Disorders and Stroke (NINDS)